BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6724355)

  • 1. Hereditary antithrombin III deficiency: biochemical aspects.
    Sas G
    Haematologia (Budap); 1984; 17(1):81-6. PubMed ID: 6724355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of the "classical" antithrombin III deficiency.
    Sas G; Petö I; Bánhegyi D; Blaskó G; Domján G
    Thromb Haemost; 1980 Jun; 43(2):133-6. PubMed ID: 7455972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
    Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
    Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ; Samson D; Stirling Y; Seghatchian MJ
    Thromb Haemost; 1985 Jun; 53(3):314-9. PubMed ID: 4049307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of familial antithrombin III variant complicated by recurrent pulmonary infarction].
    Nakano Y; Sato A; Okano A; Chida K; Yasumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):214-8. PubMed ID: 8515601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tentative classification of AT III congenital abnormalities.
    Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):661-9. PubMed ID: 2448207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited antithrombin III deficiency and cerebral thrombosis in a child.
    Ambruso DR; Jacobson LJ; Hathaway WE
    Pediatrics; 1980 Jan; 65(1):125-31. PubMed ID: 7355006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease.
    Girolami A; Pengo V; Cappellato G; Vianello C; Procidano M; Cartei C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):98-111. PubMed ID: 6192061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III deficiency: clinical aspects.
    Nagy I
    Haematologia (Budap); 1984; 17(1):87-91. PubMed ID: 6724356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III molecular variants with defective binding to heparin or to serine proteases: evidence of two different abnormal patterns identified by crossed immunoelectrofocusing.
    Leone G; De Stefano V; Ferrelli R; Teofili L; Tengborn L; Vahtera E; Bizzi B
    Thromb Haemost; 1988 Aug; 60(1):8-12. PubMed ID: 3187949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasma.
    Griffith MJ; Carraway T; White GC; Dombrose FA
    Blood; 1983 Jan; 61(1):111-8. PubMed ID: 6184096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new familial variant of antithrombin III: 'antithrombin III Paris'.
    Wolf M; Boyer C; Lavergne JM; Larrieu MJ
    Br J Haematol; 1982 Jun; 51(2):285-95. PubMed ID: 7082587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.